 Name: ___         Unit No:  ___  Admission Date: ___       Discharge Date:  ___  Date of Birth: ___       Sex:  F  Service: ORTHOPAEDICS  Allergies: Sulfa (Sulfonamide Antibiotics) / niacin  Attending: ___  Chief Complaint: Right leg pain  Major Surgical or Invasive Procedure: ___ Right femoral shaft IMN

 History of Present Illness: Ms. ___ is a ___ y/o female who presents s/p fall/guided landing during transfer from bed to wheelchair. Pt denies head trauma or LOC. Right knee buckled and now c/o pain and swelling to that knee. She has a history of right knee instability and recent admission for humeral fx on ___ currently being treated non-operatively in a splint.

 Past Medical History: Ulcerative colitis: s/p protocolectomy and end ileostomy (___) B12 replacement HTN HLD Hypothyroidism Depression Anxiety GERD Spinal stenosis Restless leg syndrome Urinary frequency

 Social History: ___ Family History: Non contributory  Physical Exam: Vital Signs: 97.4 84 141/73 16 93% ra Gen: NAD, Calm and comfortable

Upper Extremities: LUE in sling Skin clean and intact Arms and forearm compartments soft No pain with passive motion SILT in the Axillary, Radial, Median, Ulnar nerve distributions motor intact for EPL FPL EIP EDC FDP FDI 2+ radial pulses

Lower Extremities: BLE skin clean and intact Gross deformity, shortening, external rotation of right thigh No other tenderness, deformity, erythema, edema, induration or ecchymosis Thighs and leg compartments soft No pain with passive motion Saphenous, Sural, Deep peroneal, Superficial peroneal SILT ___ FHS ___ TA Peroneals Fire 1+ ___ and DP pulses  Pertinent Results: ___ 10:41AM  GLUCOSE-142* UREA N-17 CREAT-1.2* SODIUM-138 POTASSIUM-4.8 CHLORIDE-105 TOTAL CO2-24 ANION GAP-14 ___ 10:41AM  CALCIUM-8.2* PHOSPHATE-3.6 MAGNESIUM-2.0 ___ 10:40AM  WBC-16.7*# RBC-3.77* HGB-10.0* HCT-33.7* MCV-90 MCH-26.6* MCHC-29.7* RDW-15.8* ___ 10:40AM  PLT COUNT-310 ___ 11:20PM  GLUCOSE-115* UREA N-19 CREAT-1.0 SODIUM-137 POTASSIUM-5.8* CHLORIDE-106 TOTAL CO2-22 ANION GAP-15 ___ 11:20PM  estGFR-Using this ___ 11:20PM  COMMENTS-GREEN TOP ___ 11:20PM  K+-4.1 ___ 11:20PM  WBC-10.4 RBC-4.31 HGB-11.5* HCT-38.2 MCV-89 MCH-26.6* MCHC-30.0* RDW-15.9* ___ 11:20PM  NEUTS-76.5* LYMPHS-16.5* MONOS-5.8 EOS-0.9 BASOS-0.2 ___ 11:20PM  PLT COUNT-328# ___ 11:20PM  ___ PTT-31.5 ___  Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a right femoral shaft fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for R femur IMN, which the patient tolerated well (for full details please see the separately dictated operative report). The patient was taken from the OR to the PACU in stable condition and after recovery from anesthesia was transferred to the floor. 

Musculoskeletal: Prior to operation, patient was NWB RLE.  After procedure, patient's weight-bearing status was transitioned to WBAT RLE. Throughout the hospitalization, patient worked with physical therapy who determined that discharge to a rehab facility was appropriate.

Neuro: Post-operatively, patient's pain was controlled by IV pain medications and was subsequently transitioned to oxycodone with good effect and adequate pain control.

CV: The patient was stable from a cardiovascular standpoint; vital signs were routinely monitored.

Hematology: The patient was transfused 2 units of blood for acute blood loss anemia.

Pulmonary: The patient was stable from a pulmonary standpoint; vital signs were routinely monitored.

GI/GU: A po diet was tolerated well. Patient was also started on a bowel regimen to encourage bowel movement. Intake and output were closely monitored.

ID: The patient received perioperative antibiotics. The patient's temperature was closely watched for signs of infection.

Prophylaxis: The patient received enoxaparin during this stay, and was encouraged to get up and ambulate as early as possible.

At the time of discharge on ___, POD #3, the patient was doing well, afebrile with stable vital signs, tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The incision was clean, dry, and intact without evidence of erythema or drainage; the extremity was NVI distally throughout. The patient was given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient will be continued on chemical DVT prophylaxis for 2 weeks post-operatively. All questions were answered prior to discharge and the patient expressed readiness for discharge.  Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN fever or pain 2. Alendronate Sodium 70 mg PO QWED 3. Aluminum-Magnesium Hydrox.-Simethicone 15 mL PO QID:PRN indigestion/dyspepsia 4. Amlodipine 5 mg PO DAILY 5. BuPROPion (Sustained Release) 100 mg PO QAM 6. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 7. Levothyroxine Sodium 112 mcg PO DAILY 8. Lorazepam 0.5 mg PO HS 9. Omeprazole 20 mg PO DAILY 10. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain 11. Pravastatin 80 mg PO DAILY 12. Pregabalin 75 mg PO BID 13. Ropinirole 0.5 mg PO QPM 14. Sertraline 200 mg PO DAILY 15. Cepastat (Phenol) Lozenge 1 LOZ PO Q2H:PRN sore throat 16. Guaifenesin ___ mL PO Q6H:PRN cough 17. camphor-menthol ___ % topical BID PRN itching 18. Cyanocobalamin 1000 mcg IM/SC Q 2 MONTHS 19. LOPERamide 2 mg PO Q4H:PRN diarrhea 20. Lorazepam 0.5 mg PO Q6H:PRN anxiety, agitation 21. MetFORMIN (Glucophage) 500 mg PO DAILY 22. Miconazole Powder 2% 1 Appl TP BID:PRN yeast 23. Vagifem (estradiol) 10 mcg vaginal 2x/week 24. Vitamin D 50,000 UNIT PO Q 3 WEEKS 

 Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN fever or pain 2. Amlodipine 5 mg PO DAILY 3. BuPROPion (Sustained Release) 100 mg PO QAM 4. Cepastat (Phenol) Lozenge 1 LOZ PO Q2H:PRN sore throat 5. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 6. Guaifenesin ___ mL PO Q6H:PRN cough 7. Levothyroxine Sodium 112 mcg PO DAILY 8. LOPERamide 2 mg PO Q4H:PRN diarrhea 9. Lorazepam 0.5 mg PO HS 10. Lorazepam 0.5 mg PO Q6H:PRN anxiety, agitation 11. Miconazole Powder 2% 1 Appl TP BID:PRN yeast 12. Omeprazole 20 mg PO DAILY 13. Pravastatin 80 mg PO DAILY 14. Pregabalin 75 mg PO BID 15. Ropinirole 0.5 mg PO QPM 16. Sertraline 200 mg PO DAILY 17. OxycoDONE (Immediate Release) 2.5-5 mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*50 Tablet Refills:*0 18. Aluminum-Magnesium Hydrox.-Simethicone 15 mL PO QID:PRN indigestion/dyspepsia 19. Vitamin D 50,000 UNIT PO Q 3 WEEKS 20. Vagifem (estradiol) 10 mcg vaginal 2x/week 21. MetFORMIN (Glucophage) 500 mg PO DAILY 22. Cyanocobalamin 1000 mcg IM/SC Q 2 MONTHS 23. camphor-menthol ___ % topical BID PRN itching 24. Senna 17.2 mg PO HS 25. Enoxaparin Sodium 40 mg SC QPM Duration: 14 Days Start: Today - ___, First Dose: Next Routine Administration Time 

 Discharge Disposition: Extended Care  Facility: ___  Discharge Diagnosis: Right femoral shaft fracture

 Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane).

 Discharge Instructions: MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect.

ANTICOAGULATION: - Please take lovenox 40mg daily for 2 weeks

WOUND CARE: - No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining.

ACTIVITY AND WEIGHT BEARING: - WBAT RLE, range of motion as tolerated Physical Therapy: - WBAT RLE, ROMAT Treatments Frequency: - No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining.  Followup Instructions: ___ 